These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39210767)

  • 1. CYP2D6 polymorphism may contribute to Trazodone-induced hepatotoxicity: a rare case of drug-drug-gene induced liver injury.
    Ferdinande K; Declerck L; Melis C; Missiaen L; Seynhaeve L; De Vloo C; Decaestecker J
    Acta Gastroenterol Belg; 2024; 87(2):332-335. PubMed ID: 39210767
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatotoxicity due to trazodone].
    Sánchez Ruiz JC; González López E; Aparicio Tijeras C; Ezquerra Gadea J
    Aten Primaria; 2004 Jun; 34(2):104. PubMed ID: 15225535
    [No Abstract]   [Full Text] [Related]  

  • 3. Trazodone-induced hepatotoxicity: a case report with comments on drug-induced hepatotoxicity.
    Fernandes NF; Martin RR; Schenker S
    Am J Gastroenterol; 2000 Feb; 95(2):532-5. PubMed ID: 10685763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity after short-term trazodone therapy.
    Rettman KS; McClintock C
    Ann Pharmacother; 2001 Dec; 35(12):1559-61. PubMed ID: 11793619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) are associated with long term tramadol treatment-induced oxidative damage and hepatotoxicity.
    Arafa MH; Atteia HH
    Toxicol Appl Pharmacol; 2018 May; 346():37-44. PubMed ID: 29555325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trazodone-induced hepatotoxicity and leukonychia.
    Longstreth GF; Hershman J
    J Am Acad Dermatol; 1985 Jul; 13(1):149-50. PubMed ID: 4031146
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation of CpG Island Methylation of the Cytochrome P450 2E1/2D6 Genes with Liver Injury Induced by Anti-Tuberculosis Drugs: A Nested Case-Control Study.
    Zhang J; Zhu X; Li Y; Zhu L; Li S; Zheng G; Ren Q; Xiao Y; Feng F
    Int J Environ Res Public Health; 2016 Aug; 13(8):. PubMed ID: 27490558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the CYP2D6 genotype and the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine.
    Mihara K; Otani K; Suzuki A; Yasui N; Nakano H; Meng X; Ohkubo T; Nagasaki T; Kaneko S; Tsuchida S; Sugawara K; Gonzalez FJ
    Psychopharmacology (Berl); 1997 Sep; 133(1):95-8. PubMed ID: 9335086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine associated hepatotoxicity: a report of 3 cases and a review of the literature.
    Azaz-Livshits T; Hershko A; Ben-Chetrit E
    Pharmacopsychiatry; 2002 May; 35(3):112-5. PubMed ID: 12107856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients.
    Suzuki Y; Sawamura K; Someya T
    Neuropsychopharmacology; 2006 Apr; 31(4):825-31. PubMed ID: 16205777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver enzyme abnormalities during antipsychotic treatment: a case report of risperidone-associated hepatotoxicity.
    López-Torres E; Süveges A; Peñas-LLedó EM; Doña A; Dorado P; LLerena A; Berecz R
    Drug Metabol Drug Interact; 2014; 29(2):123-6. PubMed ID: 24598833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of novel reactive metabolites of trazodone: evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine.
    Wen B; Ma L; Rodrigues AD; Zhu M
    Drug Metab Dispos; 2008 May; 36(5):841-50. PubMed ID: 18238857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic active hepatitis associated with trazodone therapy.
    Beck PL; Bridges RJ; Demetrick DJ; Kelly JK; Lee SS
    Ann Intern Med; 1993 May; 118(10):791-2. PubMed ID: 8470853
    [No Abstract]   [Full Text] [Related]  

  • 14. Trazodone-induced cardiac arrhythmias: a report of two cases.
    Winkler D; Ortner R; Pjrek E; Aschauer H; Kasper S
    Hum Psychopharmacol; 2006 Jan; 21(1):61-2. PubMed ID: 16389666
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of trazodone metabolism by thioridazine in humans.
    Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Ishida M; Mihara K; Kondo T; Sugawara K; Fukushima Y
    Ther Drug Monit; 1995 Aug; 17(4):333-5. PubMed ID: 7482685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of trazodone-induced delirium.
    Lennkh C; Fischer P; Küfferle B; Kasper S
    Int Clin Psychopharmacol; 1998 Sep; 13(5):225-8. PubMed ID: 9817628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hemodialysis patient with trazodone-induced parkinsonism.
    Fukunishi I; Kitaoka T; Shirai T; Kino K; Kanematsu E; Sato Y
    Nephron; 2002 Feb; 90(2):222-3. PubMed ID: 11818711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trazodone-induced delirium: case report.
    Pereira AT; Mota D; Ribeiro L; Rodrigues JD
    Rev Colomb Psiquiatr (Engl Ed); 2020; 49(3):199-201. PubMed ID: 32888664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic predisposition to drug-induced hepatotoxicity.
    Larrey D; Pageaux GP
    J Hepatol; 1997; 26 Suppl 2():12-21. PubMed ID: 9204405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient.
    I Lorenzini K; Calmy A; Ambrosioni J; Assouline B; Daali Y; Fathi M; Rebsamen M; Desmeules J; Samer CF
    AIDS; 2012 Nov; 26(18):2417-8. PubMed ID: 23151497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.